zidovudine has been researched along with cytochrome c-t in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, A; Banks, WA; Ercal, N; Manda, KR | 1 |
Frezza, C; Grelli, S; Macchi, B; Marino-Merlo, F; Mastino, A; Matteucci, C; Minutolo, A | 1 |
2 other study(ies) available for zidovudine and cytochrome c-t
Article | Year |
---|---|
Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.
Topics: Acetylcysteine; Adenosine Triphosphate; Antiretroviral Therapy, Highly Active; Apoptosis; Blood-Brain Barrier; Caspase 3; Cell Line, Transformed; Cytochromes c; Endothelial Cells; Glutathione; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Zidovudine | 2011 |
Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Cytochromes c; Genes, bcl-2; Humans; Membrane Potential, Mitochondrial; NF-kappa B; Nitriles; Phosphorylation; Reverse Transcriptase Inhibitors; Sulfones; Transcription Factor RelA; Tumor Cells, Cultured; U937 Cells; Zidovudine | 2015 |